Pulmonary Embolism Center

Common Logjams in PE Patient Throughput (and How to Overcome Them)

Where delays occur across the pulmonary embolism care pathway and the strategies to overcome them, including a streamlined PERT program, timely anticoagulation, and emerging clinical evidence.

With Andrew J. P. Klein, MD; Sanjum S. Sethi, MD, MPH; and Catalin Toma, MD

Efficient Workflows & Clinical Algorithms

By Michael N. Young, MD

AHA/ACC Issue First Acute PE Guidelines With New Clinical Classification System

Next-Generation PERT Concepts: Ensuring Sustainability While Improving Care Pathways

Moderator Kenneth Rosenfield, MD, MHCDS, leads an expert conversation on sustaining PERT programs, preventing burnout, reducing therapeutic bias, integrating AI, and improving patient-centered PE care.

With Vivian L. Bishay, MD; Patrick Muck, MD; and Sameh Sayfo, MD, MBA, FSCAI, FACC

Pulmonary Embolism Risk Stratification: Progress, Gaps, and the Path Forward

Key developments, lessons learned, where current tools fall short, and what’s in the pipeline.

By Frances Mae West, MD, MSc, FACP; Thomas M. Todoran, MD, MSc; Andrew J. P. Klein, MD; and James Horowitz, MD

Ask The Experts: How Does PE Clot Location/Distribution Affect Your Therapy Decision-Making?

Reflections on how device selection and therapeutic approach for pulmonary embolism are impacted by factors such as thrombus location, clot burden, and patient risk profile.

With Taisei Kobayashi, MD; Riyaz Bashir, MD, FACC, RVT; and Kenneth Rosenfield, MD, MHCDS

Prepping the Room for PE Interventions

What (and who) to always have ready.

By Rohan Mundkur, MD; Akash Patel, MD; and Jonathan Paul, MD

PE and Pregnancy: What’s Your Algorithm?

Considerations regarding diagnosis and management for pulmonary embolism in pregnant patients.

With Maya Serhal, MD, FACC, FSCAI, RPVI, and Sanjum S. Sethi, MD, MPH

Study Uses The PERT Consortium Registry Data to Examine Practice Patterns and Outcomes in High-Risk Pulmonary Embolism

Balloon Pulmonary Angioplasty in CTEPH and CTEPD: Where Is This All Going?

BPA is a promising therapeutic option for inoperable CTEPH, a highly disabling consequence of PE; however, randomized controlled trials are needed to assess its ultimate benefits.

By Riyaz Bashir, MD, FACC, RVT; William R. Auger, MD, FCCP; and Kenneth Rosenfield, MD, MHCDS

Managing Right Ventricular Failure in Pulmonary Embolism

Experience and evidence for the use of mechanical circulatory support for managing high-risk PE associated with shock.

By Megan Burke, MD, and Sameer J. Khandhar, MD

Contemporary Trends in Diagnosis and Management of Pulmonary Embolism

A review of the identification and classification of acute pulmonary embolic disease and modern management strategies.

By Daniel Heikali, MD, and Suhail Dohad, MD

Management of THV Degeneration

By Janarthanan Sathananthan, MD, and S. Jay Mathews, MD